Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.290
- +0.320+4.02%
Close Dec 12 16:00 ET
- 8.540
- +0.250+3.02%
Pre 07:10 ET
161.92MMarket Cap-5.69P/E (TTM)
8.404High7.690Low45.16KVolume7.930Open7.970Pre Close364.38KTurnover1.61%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High30.26P/B23.21MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM8.96%Amplitude5.510Historical Low8.067Avg Price1Lot Size
About Actuate Therapeutics Company
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Company Profile
SymbolACTU
Company NameActuate Therapeutics
Listing DateAug 13, 2024
Issue Price8.00
Founded2015
CEOMr. Daniel M. Schmitt
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1751 River Run,Suite 400
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76107
Phone1-817-887-8455
Company Executives
- Name
- Position
- Salary
- Daniel M. Schmitt
- President, Chief Executive Officer and Director
- 520.00K
- Paul J. Lytle
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Andrew P. Mazar, PhD
- Chief Operating Officer
- 666.11K
- Dr. Aaron G.L. Fletcher, PhD
- Chairman of the Board
- 23.29K
- Jason A. Keyes
- Independent Director
- --
- Dr. Roger Sawhney
- Independent Director
- --
- Todd S. Thon
- Independent Director
- 23.29K
- Leslie W. Kreis, Jr
- Independent Director
- 23.29K
- Dr. Dan Zabrowski, PhD
- Independent Director
- 23.29K
- Amy L. Ronneberg
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
